Two novel EML4-ALK fusion variants involving EML4 exon 17 identified in lung cancer

被引：0
|
作者：
Li, Hai-Rong
Sanders, Heather R.
Sferruzza, Anthony D.
Novic, Connie
Meloni-Ehrig, Aurelia M.
Albitar, Maher
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3728
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3728
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Identification of EML4-ALK fusion in a sporadic case of cholangiocarcinoma
    Trombetta, Domenico
    Parente, Paola
    Latiano, Tiziana Pia
    Fabrizio, Federico Pio
    Muscarella, Lucia Anna
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 71 : 92 - 94
  • [42] Synergistic effects of crizotinib and radiotherapy in experimental EML4-ALK fusion positive lung cancer
    Dai, Ying
    Wei, Quanxiang
    Schwager, Christian
    Moustafa, Mahmoud
    Zhou, Cheng
    Lipson, Kenneth E.
    Weichert, Wilko
    Debus, Juergen
    Abdollahi, Amir
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (02) : 173 - 181
  • [43] EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers
    Y Fukuyoshi
    H Inoue
    Y Kita
    T Utsunomiya
    T Ishida
    M Mori
    British Journal of Cancer, 2008, 98 : 1536 - 1539
  • [44] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [45] ALK inactivation induced acquired resistance to alectinib in lung cancer harboring EML4-ALK fusion gene
    Isozaki, Hideko
    Ichihara, Eiki
    Yasugi, Masayuki
    Nobuaki, Ochi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Sendo, Toshiaki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER RESEARCH, 2014, 74 (19)
  • [46] Clinicopathologic Features of Non-Small-Cell Lung Cancer with EML4–ALK Fusion Gene
    Tsuyoshi Takahashi
    Makoto Sonobe
    Masashi Kobayashi
    Akihiko Yoshizawa
    Toshi Menju
    Ei Nakayama
    Nobuya Mino
    Shotaro Iwakiri
    Kiyoshi Sato
    Ryo Miyahara
    Kenichi Okubo
    Toshiaki Manabe
    Hiroshi Date
    Annals of Surgical Oncology, 2010, 17 : 889 - 897
  • [47] EML4-ALK fusion variants associate with gender and age in Chinese NSCLC patients
    Zhao, W.
    Liang, G.
    Wang, L.
    Dai, L.
    Wu, D.
    Wang, K.
    Wang, A.
    Chen, H.
    Dong, Y-A.
    Wang, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 43 - 43
  • [48] Novel NLRC4-ALK and EML4-ALK double fusion mutations in a lung adenocarcinoma patient: A case report
    Wu, Xueqian
    Wang, Weiya
    Zou, Bingwen
    Li, Yanying
    Yang, Xiaojuan
    Liu, Ning
    Ma, Qizhi
    Zhang, Xiaoxuan
    Wang, Yongsheng
    Li, Dan
    THORACIC CANCER, 2020, 11 (06) : 1695 - 1698
  • [49] Tacklng the EML4/ALK Fusion Oncogenes in Murine Models.
    Hawes, J.
    Vilimas, T.
    Collins, K.
    Kozlov, S.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 : S44 - S44
  • [50] Targeting EML4-ALK gene fusion variant 3 in thyroid cancer
    Aydemirli, Mehtap Derya
    van Eendenburg, Jaap D. H.
    van Wezel, Tom
    Oosting, Jan
    Corver, Willem E.
    Kapiteijn, Ellen
    Morreau, Hans
    ENDOCRINE-RELATED CANCER, 2021, 28 (06) : 377 - 389
12345